Navigation Links
Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
Date:12/17/2009

3 Others 19

4.4 Product Profiles of the Major Marketed Products in the NPWT Market 21

4.4.1 V.A.C Therapy System 21

4.4.1.1 Overview 21

4.4.1.2 Efficacy 21

4.4.1.3 Safety Profile 21

4.4.1.4 Pricing 21

4.4.1.5 Clinical Study details 21

4.4.2 RENASYS System 24

4.4.2.1 Overview 24

4.4.2.2 Efficacy 24

4.4.2.3 Safety 24

4.4.2.4 Pricing 24

4.4.2.5 Clinical Study Details 25

4.5 Key Takeaway 25

5 Global NPWT Market: Pipeline Assessment 26

5.1 Overview 26

5.2 Strategic Pipeline Assessment 26

5.3 NPWT - Pipeline by Clinical Phase of Development 29

5.4 Profiles of Promising Devices in Clinical Development 30

5.4.1 DermaStream CST 30

5.4.1.1 Overview 30

5.4.1.2 Efficacy 30

5.4.1.3 Safety 30

5.4.1.4 Clinical Study Details 30

5.4.2 V.A.C. Therapy system 32

5.4.2.1 Overview 32

5.4.2.2 Efficacy 32

5.4.2.3 Safety 32

5.4.2.4 Clinical Study Details 32

5.5 NPWT Market: List of Pipeline Products 33

5.6 Key Takeaway 33

6 Global NPWT Market : Implications for Future Market Competition 34

6.1 Strategic Competitor Assessment 35

7 Global NPWT Market: Emerging Companies 36

7.1 Introduction 36

7.1.1 EnzySurge Ltd. 36

7.1.1.1 Overview 36

7.1.1.2 NPWT Portfolio 36

8 Appendix 37

8.1 Definitions 37

8.1.1 Negative Pressure Wound Therapy (NPWT) 37

8.1.1.1 Negative Pressure Wound Therapy Disposables 37

8.1.1.2 Negative Pressure Wound Therapy Equipment 37

8.2 Research Methodology 38

8.3 Secondary Research 38

8.4 Primary Research 39

8.5 Models 40

8.6 Forecasts 40

8.7 Expert
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
2. Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
3. Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
4. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
5. Reportlinker Adds Top Ten Worlds Leading Orthopedics Companies
6. Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
7. Reportlinker Adds Medical Fiber Optics - A World Market Analysis
8. Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities
9. Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis
10. Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide
11. Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014  Celsion Corporation (NASDAQ: CLSN ) ... call to discuss its second quarter 2014 financial results ... To participate in the call, interested parties may dial ... (International/Toll) and ask for the Celsion Corporation Second Quarter ... minutes before the call is scheduled to begin. The ...
(Date:7/31/2014)... PARK, North Carolina , 31. Juli 2014 ... Einrichtungen in Miami bekanntgegeben, ... Studien in Zentral- und Lateinamerika zu erfüllen. Die ... für eingehende biologische Proben und für die Zusammenlegung ... und sie wird zusätzliche Lagerkapazität bereitstellen.   ...
(Date:7/31/2014)... 2014 Second Quarter Total Revenue $2.0 billion; an increase of ... 4% for same store sales and 8% pro forma, excluding ... , 2014 Second Quarter GAAP EPS $0.37; Cash EPS $1.91, ... Operating Cash Flow $376 million; Adjusted Operating Cash Flow $500 ... Launched 17 new products in the U.S. year-to-date , ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Marken erweitert regionales Logistikzentrum in Miami 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32
... ... ... ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... Novo Nordisk, a world leader ... (EIC) are launching a collaborative project to enhance ... the media to improve public awareness of the ... (Logo: http://photos.prnewswire.com/prnh/20020404/NVOLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20020404/NVOLOGO) ...
Cached Medicine Technology:Warner Chilcott Announces FDA Approval of New Oral Contraceptive 2Warner Chilcott Announces FDA Approval of New Oral Contraceptive 3Warner Chilcott Announces FDA Approval of New Oral Contraceptive 4Warner Chilcott Announces FDA Approval of New Oral Contraceptive 5Warner Chilcott Announces FDA Approval of New Oral Contraceptive 6Warner Chilcott Announces FDA Approval of New Oral Contraceptive 7Warner Chilcott Announces FDA Approval of New Oral Contraceptive 8Warner Chilcott Announces FDA Approval of New Oral Contraceptive 9Novo Nordisk and Entertainment Industries Council Work Together to Improve Public Education and Awareness about Diabetes Epidemic 2Novo Nordisk and Entertainment Industries Council Work Together to Improve Public Education and Awareness about Diabetes Epidemic 3Novo Nordisk and Entertainment Industries Council Work Together to Improve Public Education and Awareness about Diabetes Epidemic 4Novo Nordisk and Entertainment Industries Council Work Together to Improve Public Education and Awareness about Diabetes Epidemic 5
(Date:7/31/2014)... Mellon University have developed a novel method for ... fibers found in living cells. The work offers ... drug delivery and tissue engineering applications. The findings ... Angewandte Chemie International Edition . , "We ... protein molecules, we can form completely new types ...
(Date:7/31/2014)... Dennis Thompson HealthDay Reporter ... largest maker of a surgical tool that has shown an ... it will withdraw its device from the market. In ... its customers Thursday, Johnson & Johnson asked that its laparoscopic ... Street Journal reported. Sales of new morcellators ...
(Date:7/31/2014)... Ottawa, Ontario (PRWEB) July 31, 2014 ... s deliver fitness to your home, which now includes ... certified personal trainers have been delivering fitness to clients ... Ottawa. Fitness on the Go is a Canadian owned ... to helping communities achieve a healthier and fitter lifestyle. ...
(Date:7/31/2014)... All Star Comedy Night will take place on August 7th ... Avery Moskowitz who has Neuroblastoma, a form of childhood cancer. ... both have multiple ties to Avery and her family. Together, ... hard at securing sponsors. Avery's story is being documented daily ... Atlantic Toyota and NY Auto Giant has ...
(Date:7/31/2014)... 31, 2014 During the July 2014 ... Foundation, mesothelioma expert and executive director of the Mesothelioma ... patients today have more promising clinical trials to choose ... mentioned several trials that have been reporting increased survival ... the focus of others is within the field of ...
Breaking Medicine News(10 mins):Health News:Carnegie Mellon chemists create nanofibers using unprecedented new method 2Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 2Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 3Health News:Fitness on the Go Grows to Ottawa 2Health News:Local Long Island Massage Day Spa and Auto Dealer Combine Forces to Raise Funds for 4 Year Old Who Has Cancer 2Health News:Local Long Island Massage Day Spa and Auto Dealer Combine Forces to Raise Funds for 4 Year Old Who Has Cancer 3Health News:‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert 2Health News:‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert 3
... Golf can be a good investment for the health, according ... Institutet. The death rate for golfers is 40 per cent ... and socioeconomic status, which correspond to a 5 year increase ... safest. , It is a well-known fact that exercise ...
... 2008) Results from a pivotal Phase III ... oral, once-daily, investigational anticoagulant medication, was superior in ... total knee replacement (TKR) surgery. The head-to-head study ... enoxaparin, the current standard of care. , Data ...
... May 30 Lutronic, Inc., one of,the world,s ... today that its MOSAIC eCO2 system, the next ... the deep,ablative features of a CO2 laser, is ... With intuitive touch-screen software, the powerful MOSAIC ...
... May 30 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... been notified by,the American Stock Exchange (the "AMEX") ... for regaining compliance with the continued listing,standards and ... stock from the,Exchange by filing a delisting application ...
... less likely than white women to receive the radiation ... according to a study that Dana-Farber Cancer Institute researchers ... Society of Clinical Oncology in Chicago. , Although the ... that thousands of black and Hispanic breast cancer patients ...
... COLUMBUS, Ohio Medical researchers at The Ohio State ... a $34 million grant from the National Institutes of ... translational protocols that help identify and advance treatments for ... received by Ohio State. , The Ohio State University ...
Cached Medicine News:Health News:Golf prolongs life 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 3Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 2Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 3Health News:Delisting Notification Received from the American Stock Exchange 2Health News:Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer 2Health News:Ohio State receives $34M NIH grant 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: